|
Re: Zenith A Loser Too
|
7
|
Zenith Epigenetics
|
Jun 16, 2020 03:18PM
|
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 06:59AM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 05:45PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 05:54PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:10PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:27PM
|
|
Re: The Biotech Blindspot
|
5
|
Resverlogix Corp.
|
Jul 04, 2020 07:08PM
|
|
Re: Is this sleeping beauty
|
8
|
Resverlogix Corp.
|
Jul 16, 2020 07:27PM
|
|
Re: One monkey off....
|
7
|
Resverlogix Corp.
|
Jul 22, 2020 09:55AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
7
|
Resverlogix Corp.
|
Jul 24, 2020 11:40AM
|
|
BNP
|
6
|
Resverlogix Corp.
|
Sep 01, 2020 11:03AM
|
|
Re: August 2, 2020 Article - British Journal of Anesthesia - mentions Apabetalone & COVID
|
5
|
Resverlogix Corp.
|
Sep 10, 2020 11:03AM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
4
|
Resverlogix Corp.
|
Sep 18, 2020 09:07AM
|
|
Re: Ground Hog Day
|
2
|
Resverlogix Corp.
|
Sep 18, 2020 04:24PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
5
|
Resverlogix Corp.
|
Sep 19, 2020 04:02PM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
6
|
Zenith Epigenetics
|
Oct 05, 2020 07:08PM
|
|
Re: December 22, 2020.
|
9
|
Resverlogix Corp.
|
Oct 10, 2020 10:14AM
|
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 16, 2020 06:56PM
|
|
Re: The problem...as I see it
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 11:22AM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 11:29AM
|
